Hellman Jordan Management Company’s iShares Biotechnology ETF IBB Stock Holding History

Hellman Jordan Management Company’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$3.57M	Buy	27,197 +10,631	+64%	+$1.37M	6.06%	3
2022 Q3	$1.94M	Buy	16,566 +2,212	+15%	+$275K	3.36%	10
2022 Q2	$1.69M	Sell	14,354 -781	-5%	-$92.7K	2.27%	13
2022 Q1	$1.97M	Buy	15,135 +2,273	+18%	+$296K	2.14%	16
2021 Q4	$1.96M	Buy	+12,862	New	+$1.99M	2.36%	15

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CANY

Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Hellman Jordan Management Company's IBB Position: Q4 2022 in Review

Hellman Jordan Management Company increased its iShares Biotechnology ETF (IBB) stake by 64% in Q4 2022, buying an estimated $1.37M and bringing the position to 27,197 shares worth $3.57M. The position accounts for 6.06% of the portfolio, ranked #3.

Hellman Jordan Management Company first reported a position in IBB in Q4 2021 and has held it in 5 quarters since. 902 funds tracked by Wall St. Rank hold IBB as of Q4 2022.

Hellman Jordan Management Company held 27,197 shares of iShares Biotechnology ETF worth $3.57M as of Q4 2022.
Hellman Jordan Management Company bought 10,631 iShares Biotechnology ETF shares in Q4 2022, an estimated $1.37M.
iShares Biotechnology ETF made up 6.06% of Hellman Jordan Management Company's portfolio in Q4 2022, its #3 holding.
Hellman Jordan Management Company first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 5 quarters since.
902 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2022.

Based on Hellman Jordan Management Company's 13F filing for Q4 2022, filed 20 Jan 2023.